Tilray Shares Face Renewed Pressure as Analyst Slashes Price Target

Investor optimism for a near-term recovery has been dashed. Tilray Brands, Inc. continues to experience significant selling pressure following its recent reverse stock split, a situation compounded by a major investment bank’s decision to drastically reduce its valuation estimate for the company. This dual setback visibly unsettled the market, driving the share price lower in the latest trading session.

Fundamental Challenges Overshadow Rating

The immediate catalyst for the latest decline was a stark reassessment by analysts at TD Cowen. The firm has substantially cut its price target on Tilray shares from $25 to just $10. While the analysts maintained a “Buy” recommendation, the dramatic reduction in the target price underscores deeper concerns. The revision was attributed to persistent headwinds in the craft beer segment and ongoing competitive intensity within the Canadian cannabis market. This downward adjustment in valuation is currently carrying more weight with investors than the maintained positive operational rating.

Market Skepticism Follows Reverse Split

A key technical event has set the stage for the current volatility. On December 1, Tilray executed a 1-for-10 reverse stock split. This corporate action reduced the number of outstanding shares from approximately 1.16 billion to about 116 million. Management’s stated goal was to align the company’s capital structure with industry peers and maintain compliance with exchange listing standards. Historically, however, such moves are often viewed by the market as a sign of weakness. The response has been negative, with increased volatility and a further 2% drop in the share price yesterday, indicating investor distrust of what is perceived as artificial financial engineering.

Should investors sell immediately? Or is it worth buying Tilray?

Operational Progress Goes Unnoticed

Beneath the technical stock price turmoil, Tilray’s most recent business fundamentals show a measure of improvement. For the first quarter of its fiscal year 2026, the company reported a 5% increase in net revenue, reaching $210 million. More notably, it posted a net income of $1.5 million, marking a return to profitability after periods of loss.

Strategically, the company is attempting to reduce its reliance on the volatile core cannabis business. Management is placing greater emphasis on expansion within the beverage sector, particularly for hemp-based THC-infused drinks. For now, however, these operational advances and strategic shifts are being largely ignored by the market. Trader focus remains fixed on the post-split technical selling and the sharply lowered analyst valuation.